Serum free light chains (SFLC) assay in IgD multiple myeloma (MM)

被引:0
|
作者
Giarin, M. M. [1 ]
Giaccone, L. [1 ]
Oddolo, D. [1 ]
Bringhen, S. [1 ]
Ricci, G. [1 ]
Sfiligoi, C. [1 ]
Astolfi, M. [1 ]
Omede, P. [1 ]
Cavallo, F. [1 ]
Amoroso, B. [1 ]
Boccadoro, M. [1 ]
机构
[1] Univ Turin, Azienda Osped San G Battista Torino, Div Ematol, Turin, Italy
来源
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:172 / 172
页数:1
相关论文
共 50 条
  • [21] Diagnostic thresholds for free light chains in multiple myeloma depend on the assay used
    Xavier Bossuyt
    Michel Delforge
    Martin Reynders
    Doreen Dillaerts
    Ben Sprangers
    Karel Fostier
    Koen Poesen
    Martine Vercammen
    Leukemia, 2018, 32 : 1815 - 1818
  • [22] Diagnostic thresholds for free light chains in multiple myeloma depend on the assay used
    Bossuyt, Xavier
    Delforge, Michel
    Reynders, Martin
    Dillaerts, Doreen
    Sprangers, Ben
    Fostier, Karel
    Poesen, Koen
    Vercammen, Martine
    LEUKEMIA, 2018, 32 (08) : 1815 - 1818
  • [23] The Roles of Serum Free Light Chain Assay on The Prognosis of Multiple Myeloma
    Watanaboonyongcharoen, P.
    Suwannabutra, S.
    Theerasaksilp, S.
    Paripokee, N.
    Nakorn, T. Na
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S66 - S66
  • [24] Light chain multiple myeloma: when the response will it be evaluated by serum free light chains?
    Corre, Jill
    Avet-Loiseau, Herve
    Hematologie, 2016, 22 (06): : 393 - 394
  • [25] Follow-up of IgD-κ multiple myeloma by monitoring free light chains and total heavy chain IgD: A case report
    De Santis, Elena
    Masi, Serena
    Cordone, Iole
    Pisani, Francesco
    Zuppi, Cecilia
    Mattei, Fabrizio
    Conti, Laura
    Cigliana, Giovanni
    ONCOLOGY LETTERS, 2016, 12 (03) : 1884 - 1888
  • [26] Prognostic Value of Serum Free Light Chains Measurements in Multiple Myeloma Patients
    de Veas Silva, Jose Luis Garcia
    Guitarte, Carmen Bermudo
    Valladares, Paloma Menendez
    Rojas Noboa, Johanna Carolina
    Kestler, Krysta
    Millan, Rafael Duro
    PLOS ONE, 2016, 11 (11):
  • [27] Potential of serum free light chains for managing patients with multiple myeloma and amyloidosis
    Bradwell, AR
    Carr-Smith, HD
    Mead, GP
    Harvey, TC
    BONE MARROW TRANSPLANTATION, 2002, 29 : S98 - S99
  • [28] Serum free light chains for diagnosis and follow-up of multiple myeloma
    Jung, Seonkyung
    Kim, Myungshin
    Lim, Jihyang
    Kim, Yonggoo
    Han, Kyungja
    Min, Chang-Kee
    Min, Woo-Sung
    KOREAN JOURNAL OF LABORATORY MEDICINE, 2008, 28 (03): : 169 - 173
  • [29] Detection and monitoring of nonsecretory myeloma using an assay for free light chains in serum.
    Bradwell, AR
    Carr-Smith, HD
    Smith, L
    Mead, GP
    CLINICAL CHEMISTRY, 2001, 47 (06) : A43 - A44
  • [30] PROGNOSTIC IMPACT OF SERUM FREE LIGHT CHAIN (SFLC) EVALUATION IN PATIENTS WITH NEWLY DIAGNOSED SYMPTOMATIC MULTIPLE MYELOMA (MM) RECEIVING BORTEZOMIB (BTZ) - BASED REGIMENS
    Tacchetti, P.
    Zamagni, E.
    Pezzi, A.
    Rocchi, S.
    Pantani, L.
    Marzocchi, G.
    Zannetti, B. A.
    Borsi, E.
    Mancuso, K.
    Dico, F. A.
    Rizzello, I.
    Terragna, C.
    Cavo, M.
    HAEMATOLOGICA, 2015, 100 : 514 - 514